ImaginAb are world leaders in the development of immunoPET and our late-stage imaging agent is utilized in a rapidly increasing number of trials. Alongside ImaginAb sponsored studies, we work with some of the world’s largest pharmaceutical companies and most innovative biotech’s to study CD8+ cell distribution in patients prior to and during immunotherapy, to better understand the action of this critical class of cancer medicine.

OUR VISION AND PURPOSE
We have a clear purpose and vision; Our purpose, which drives us each day, is to “challenge, create and transform patient care” and, by doing so, achieve our vision which is to become “the lead diagnostic and treatment choice, helping patients live better and healthier lives”.

OUR CULTURE
Our culture is vital and underpins our vision and purpose. Quite simply we believe we are different. We are a small but dynamic business with a strong culture which we are proud of. We are diverse, inclusive and believe in working closely as one team, not only with our colleagues but also with our key external partners.

We look for the best and invest in our people and take pride in having a team of passionate and diligent people, working together with a united purpose. In short, we love what we do … and while every one of ‘team ImaginAb’ brings something unique to our business, all are driven by the desire of making a real difference in the world of patient care and helping ImaginAb become the most impactful business in the world of cancer treatment.

ImaginAb is an is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.